Is VNUED or JNJ a better dividend investment in 2026?

VNUED currently yields 5277.04% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: VNUED offers higher current income.

What is the dividend yield difference between VNUED and JNJ?

VNUED has a forward dividend yield of 5277.04% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 5274.91 percentage points.

Home › Compare › VNUED vs JNJ

VNUED vs JNJ: Dividend Comparison 2026

VNUED yields 5277.04% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 VNUED wins by $105092487862786.61M in total portfolio value

INVESTMENT

TIME HORIZON10 years

VNUED

● Live price

5277.04%

Share price

$0.04

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$105092487862786.64M

Annual income

$101,315,690,369,019,080,000.00

Full VNUED calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — VNUED vs JNJ

📍 VNUED pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	VNUED	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, VNUED + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

VNUED pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VNUED

Annual income on $10K today (after 15% tax)

$448,548.81/yr

After 10yr DRIP, annual income (after tax)

$86,118,336,813,666,220,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, VNUED beats the other by $86,118,336,813,666,220,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VNUED + JNJ for your $10,000?

VNUED: 50%JNJ: 50%

100% JNJ50/50100% VNUED

Portfolio after 10yr

$52546243931393.34M

Annual income

$50,657,845,184,509,540,000.00/yr

Blended yield

96.41%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VNUED

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VNUED buys

JNJ buys

No recent congressional trades found for VNUED or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricVNUEDJNJ

Forward yield	5277.04% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$105092487862786.64M ✓	$30.3K
Annual income after 10y	$101,315,690,369,019,080,000.00 ✓	$4,689.40
Total dividends collected	$104837398059661.33M ✓	$15.4K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: VNUED vs JNJ ($10,000, DRIP)

Year	VNUED Portfolio	VNUED Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$538,404	$527,704.49	$10,592	$272.30	+$527.8K → VNUED
2	$27,129,220	$26,553,127.29	$11,289	$357.73	+$27.12M → VNUED
3	$1,279,461,590	$1,250,433,324.20	$12,123	$472.89	+$1279.45M → VNUED
4	$56,483,629,665	$55,114,605,764.38	$13,141	$629.86	+$56483.62M → VNUED
5	$2,334,373,664,785	$2,273,936,181,043.18	$14,408	$846.81	+$2334373.65M → VNUED
6	$90,327,656,377,649	$87,829,876,556,328.61	$16,021	$1,151.60	+$90327656.36M → VNUED
7	$3,272,858,055,269,529	$3,176,207,462,945,445.00	$18,122	$1,588.22	+$3272858055.25M → VNUED
8	$111,057,182,876,077,860	$107,555,224,756,939,470.00	$20,930	$2,228.20	+$111057182876.06M → VNUED
9	$3,529,717,283,894,910,500	$3,410,886,098,217,507,300.00	$24,792	$3,191.91	+$3529717283894.89M → VNUED
10	$105,092,487,862,786,640,000	$101,315,690,369,019,080,000.00	$30,274	$4,689.40	+$105092487862786.61M → VNUED

VNUED vs JNJ: Complete Analysis 2026

VNUED — Stock

Redacted Industries, Inc. provides optics technologies for the defense and law enforcement industries in the United States. The company offers thermal, sensor, and augmented optics and optical and digital imaging technology, specializing in advanced firearm optics, thermal imaging, and augmented glass solutions. The company was formerly known as VNUE, Inc. and changed its name to Redacted Industries, Inc. in December 2025. Redacted Industries, Inc. was incorporated in 2006 and is based in New York, New York.

Full VNUED Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this VNUED vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VNUED vs SCHD VNUED vs JEPI VNUED vs O VNUED vs KO VNUED vs MAIN VNUED vs ABBV VNUED vs MRK VNUED vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.